Virendra Gajbhiye

Employment

• Agharkar Research Institute Scientist in Nanomedicine
  2013 - Present
• Oregon Health and Science University Postdoctoral Research Associate
  2013 - 2013
• Wisconsin Institute for Discovery Postdoctoral Fellow
  2012 - 2013
• Sagar Institute of Pharmaceutical Science Lecturer in Pharmaceutics
  2011 - 2012
• Bansal College of Pharmacyturer in Pharmaceutics Lecturer in Pharmaceutics
  2007 - 2008

Education

• Dr Hari Singh Gour University Department of Pharmaceutical Sciences PhD
  ? - 2011
• Dr Hari Singh Gour University Department of Pharmaceutical Sciences Master in Pharmacy (Pharmaceutics)
  ? - 2007

Projects & Funding

Projects & funding information is unavailable.

Publications (89)

• Nucleolin aptamer conjugated MSNPs-PLR-PEG multifunctional nanoconstructs for targeted co-delivery of anticancer drug and siRNA to counter drug resistance in TNBC
  International Journal of Biological Macromolecules 2023 DOI: 10.1016/j.ijbiomac.2022.12.266
  +Save
• A combinatorial delivery of survivin targeted siRNA using cancer selective nanoparticles for triple negative breast cancer therapy
  Journal of Drug Delivery Science and Technology 2023 DOI: 10.1016/j.jddst.2023.104164
  +Save
• Targeted silencing of the MCL-1 gene using multi-layered dendrimer-based nanoconstructs achieves efficient tumor regression in xenografted mice models
  International Journal of Pharmaceutics 2023 DOI: 10.1016/j.ijpharm.2023.122659
  +Save
• Challenges and emerging strategies for next generation liposomal based drug delivery: An account of the breast cancer conundrum
  Chemistry and Physics of Lipids 2023 DOI: 10.1016/j.chemphyslip.2022.105258
  +Save
• Tenofovir-tethered gold nanoparticles as a novel multifunctional long-acting anti-HIV therapy to overcome deficient drug delivery-: an in vivo proof of concept
  Journal of Nanobiotechnology 2023 DOI: 10.1186/s12951-022-01750-w
  +Save
• Aptamer Tethered Bio-Responsive Mesoporous Silica Nanoparticles for Efficient Targeted Delivery of Paclitaxel to Treat Ovarian Cancer Cells
  Journal of Pharmaceutical Sciences 2023 DOI: 10.1016/j.xphs.2023.01.011
  +Save
• Protein nanocapsules as a smart drug delivery platform
  Stimuli-Responsive Nanocarriers 2022 DOI: 10.1016/b978-0-12-824456-2.00010-2
  +Save
• Vesicular nanocarrier based stimuli-responsive drug delivery systems
  Stimuli-Responsive Nanocarriers 2022 DOI: 10.1016/b978-0-12-824456-2.00002-3
  +Save
• Tailored gold nanoparticles for improved control over drug release
  Stimuli-Responsive Nanocarriers 2022 DOI: 10.1016/b978-0-12-824456-2.00008-4
  +Save
• Stimuli-responsive strategies: Role of various molecules/moieties facilitating the design of stimuli-responsive nanocarriers
  Stimuli-Responsive Nanocarriers 2022 DOI: 10.1016/b978-0-12-824456-2.00013-8
  +Save